HintonJamesHeel
Esteemed Member
- Messages
- 672
The drug, which is being brought to the commercial market by drugmaker Gilead Sciences, builds on NIH-backed research into earlier HIV medications. The drug's availability could lead to a significant drop in HIV cases worldwide, since a study found it was 100% effective in preventing transmission.Trump administration ending multiple HIV vaccine studies, scientists and officials say
![]()
Trump administration ending multiple HIV vaccine studies, scientists and officials say
"This is a setback of probably a decade for HIV vaccine research," one scientist said.www.cbsnews.com
“The Trump administration has moved to end funding for a broad swath of HIV vaccine research, saying current approaches are enough to counter the virus, multiple scientists and federal health officials say.
Notifications that the funding would not be extended were relayed Friday to researchers, who were told by National Institutes of Healthofficials that the Department of Health and Human Services had elected "to go with currently available approaches to eliminate HIV" instead…”
This is so great. I had no idea we had come so far.